Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
Keywords:
Clinical trials
Drug therapies
MAFLD
NAFLD
NASH
Note:
This article is licensed under a Creative Commons Attribution 4.0 International License
Citation:
Sangro, P. (Paloma); de-la-Torre-Aláez, M. (Manuel); Sangro, B. (Bruno); et al. "Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment". Journal of Physiology and Biochemistry. 79, 2023, 869 - 879
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.